NKR-2

· Celyad Oncology SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKR-2, covering 2021-05-04 to 2021-05-04. Get the full timeline:

Most recent: Clinical Trial Update: DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2 [Phase 1, Phase 2]